Baxter International Inc. BAX
$26.16
-2.21%
at last close
Market Cap$13.52 billion
P/E Ratio—
Div Yield0.15%
Volume9.28M
52-Week Range
$15.73$31.75
Key Stats
- Today's Range
- $26.02 – $27.14
- 50-Day Range
- $18.01 – $30.00
- 52-Week Range
- $15.73 – $31.75
- Volume
- 9.28 million shs
- Average Volume
- 6.78 million shs
- Market Cap
- $13.52 billion
- P/E Ratio
- —
- Dividend Yield
- 0.15%
Valuation
- P/E Ratio
- —
- Price / Book
- 2.19
- Price / Sales
- 1.18
Dividend
- Dividend Yield
- 0.15%
- Annual Dividend
- $0.04
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-08-28
Short Interest
- Short Interest
- 1.03%
- Days to Cover
- 2.52
Financials (TTM)
- Revenue
- $11.47 billion
- Net Income
- $-1,063,000,000
- Net Margin
- -9.27%
- Return on Equity
- -17.20%
- Debt-to-Equity
- —
About Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.